极低出生体质量患儿出生早期血清Nesfatin-1表达水平变化

doi:10.3969/j.issn.1674-490X.2025.01.003

摘要/Abstract

摘要： 目的探究血清Nesfatin-1在极低出生体质量患儿中的表达及临床意义。方法选取2020年10月至2024年8月在河北大学附属医院出生并于出生后即转入新生儿重症监护室住院的89例极低出生体质量患儿作为研究对象,依据出生胎龄分为3组,A组(胎龄<28周)10例,B组(胎龄28~30周)20例,C组(胎龄>30周)59例,检测并观察所有患儿出生早期血清Nesfatin-1水平变化规律。结果胎龄<28周患儿出生第1 天、7 天、14 天、1个月及3个月血清Nesfatin-1水平显著高于胎龄28~30周和胎龄 >30周,差异有统计学意义(P<0.05);且随着胎龄的增长,血清Nesfatin-1水平呈逐渐下降趋势;各个胎龄时间段血清Nesfatin-1在出生第1 天表达水平均最高,但在出生的前7 d呈下降趋势,随后逐渐升高,出生14 d后随着出生日龄的延长,血清Nesfatin-1水平呈下降趋势,差异有统计学意义(P<0.05);胎龄<28周患儿体质量增长速率、身长增长速率及头围增长速率均显著低于胎龄28~30周和胎龄>30周,差异有统计学意义(P<0.05);高水平血清Nesfatin-1与新生儿体质量增长速率、身长增长速率及头围增长速率呈负相关(r分别为-0.652、-0.503、-0.589,均P<0.05)。结论极低出生体质量患儿出生早期血清Nesfatin-1水平存在动态变化,且与体格生长发育存在一定相关性,临床上可将其作为极低出生体质量患儿生长管理的依据。

关键词: 极低出生体质量, Nesfatin-1, 追赶性生长, 体格发育

Abstract: Objective To explore the expression and clinical significance of serum Nesfatin-1 in children with very low birth body mass.Methods 89 cases of children with very low body quality born in and after birth transferred into neonatal intensive care unit were selected from October 2020 to August 2024 in Affiliated Hospital of Hebei University as the study object. According to birth gestational age, they were divided into 3 groups, group A(gestational age <28 weeks, 10 cases), group B(gestational age 28-30 weeks, 20 cases), group C(gestational age >30 weeks, 59 cases), early serum Nesfatin-1 level changes of all children were detected and examinated.Results Children with gestational age <28 weeks had significantly higher serum Nesfatin-1 levels on days 1, 7, 14, 1 month and 3 months than that of gestational age 28 to 30 weeks and gestational age >30 weeks, the difference was statistically significant(P<0.05). With increasing gestational age, serum Nesfatin-1 level showed a gradual decline. The expression level of serum Nesfatin-1 was highest at day 1 of birth for each gestational age period, but showed a decreasing trend during the first 7 days of life, following a gradual elevation, with the increasing age of birth after 14 days of life, falling trend in serum Nesfatin-1 levels, the difference was statistically significant(P<0.05). The growth rate of body mass, body length and head circumference of children with gestational age <28 weeks were significantly lower than that of the gestational age of 28 to 30 weeks and the gestational age of >30 weeks, the difference was statistically significant(P<0.05). High levels of serum Nesfatin-1 were negatively associated with the growth rate of neonatal body mass, body length and head circumference(r was -0.652, -0.503 and -0.589, respectively, P for all <0.05).Conclusion The serum Nesfatin-1 level changes dynamically in the early birth, and it has some correlation with the physical growth and development, which can be used clinically as the basis for the growth management of children with very low birth body quality.

Key words: very low birth mass, Nesfatin-1, catch-up growth, physical development

中图分类号:

杨叶,王玉. 极低出生体质量患儿出生早期血清Nesfatin-1表达水平变化[J]. 医学研究与教育, 2025, 42(1): 26-34.

参考文献

[1] 付贞艳,张霞,胡雁,等.极低出生体重儿母亲在母婴分离期泌乳维持最佳证据总结[J].中国实用护理杂志, 2021, 37(1): 18-25. DOI: 10.3760/cma.j.cn211501-20200222-00550.
[2] STARC M, GIANGRECO M, CENTOMO G, et al. Extrauterine growth restriction in very low birth weight infants according to different growth charts: a retrospective 10 years observational study[J]. PLoS One, 2023, 18(4): e0283367. DOI: 10.1371/journal.pone.0283367.
[3] PHAM V, PEMBERTON J G, CHANG J P, et al. Nesfatin-1 stimulates the hypothalamus-pituitary-interrenal axis hormones in goldfish[J]. Am J Physiol Regul Integr Comp Physiol, 2021, 321(4): 603-613. DOI: 10.1152/ajpregu.00063.2021.
[4] ZHENG J Y, HAN J, WANG Y, et al. Role of brain NUCB2/nesfatin-1 in stress and stress-related gastrointestinal disorders[J]. Peptides, 2023, 167: 171043. DOI: 10.1016/j.peptides.2023.171043.
[5] 杨冬菲,钟小毅,向晶晶,等.不同胎龄早产儿支气管肺发育不良的临床特点及危险因素分析[J].医学研究与教育, 2022, 39(5): 13-18. DOI: 10.3969/j.issn.1674-490X.2022.05.003.
[6] 钟小毅,杨冬菲,孙东明,等.早产小于胎龄儿发生的危险因素分析[J].医学研究与教育, 2023, 40(1): 59-63. DOI: 10.3969/j.issn.1674-490X.2023.01.009.
[7] XIANG Y, TANG Q Y, WANG Y, et al. Nutrition profile of very low birth weight infants with extrauterine growth restriction in NICU[J]. Clin Nutr ESPEN, 2021, 42: 252-257. DOI: 10.1016/j.clnesp.2021.01.027.
[8] ZHANG Y H, ZHOU J, MA Y B, et al. Mode of delivery and preterm birth in subsequent births: a systematic review and meta-analysis[J]. PLoS One, 2019, 14(3): e0213784. DOI: 10.1371/journal.pone.0213784.
[9] 姚清山,葛品,刘桂华,等.早产儿6月龄追赶生长状况及影响因素分析[J].海峡预防医学杂志, 2021, 27(6): 17-18.
[10] 王雪芹,何婧,何敏,等.父母参与发展性照顾联合袋鼠式干预对极低出生体重儿生长发育、神经行为及胃饥饿素水平的影响[J].中国儿童保健杂志, 2021, 29(3): 313-317. DOI: 10.11852/zgetbjzz2020-0913.
[11] CHEONG J L Y, BURNETT A C, TREYVAUD K, et al. Early environment and long-term outcomes of preterm infants[J]. J Neural Transm(Vienna), 2020, 127(1): 1-8. DOI: 10.1007/s00702-019-02121-w.
[12] WANG S, GU J, BIAN J, et al. Nesfatin-1 mitigates calcific aortic valve disease via suppressing ferroptosis mediated by GSH/GPX4 and ZIP8/SOD2 axes[J]. Free Radic Biol Med, 2024,222: 149-164. DOI: 10.1016/j.freeradbiomed.2024.06.004.
[13] ZHOU S Y, NAO J F. Nesfatin-1: a biomarker and potential therapeutic target in neurological disorders[J]. Neurochem Res, 2024, 49(1): 38-51. DOI: 10.1007/s11064-023-04037-0.
[14] 杨娟,冷茂东,孙倩倩,等.Nesfatin-1、瘦素在肥胖儿童的表达水平及临床意义[J].重庆医学, 2023, 52(5): 701-704, 709. DOI: 10.3969/j.issn.1671-8348.2023.05.013.
[15] DAMIAN-BUDA A C, MATEI D M, CIOBANU L, et al. Nesfatin-1: a novel diagnostic and prognostic biomarker in digestive diseases[J]. Biomedicines, 2024, 12(8): 1913. DOI: 10.3390/biomedicines12081913.
[16] RUPP S K, STENGEL A. Interactions between nesfatin-1 and the autonomic nervous system:an overview[J]. Peptides, 2022, 149: 170719. DOI: 10.1016/j.peptides.2021.170719.
[17] FILIBELI B E, BAYRAKTAR M K, AKSUN S, et al. The effect of breast milk nesfatin-1 and ghrelin levels on growth in infants with SGA[J]. Turk J Pediatr, 2022, 64(2): 239-245. DOI: 10.24953/turkjped.2021.1075.
[18] HONORÉ K D, BRUUN S, JACOBSEN L N, et al. Nesfatin-1 in human milk and its association with infant anthropometry[J]. Nutrients, 2022, 15(1): 176. DOI: 10.3390/nu15010176.
[19] 曾欢英,刘艳红,何金花,等.孕21~24周临床结合超声 Nesfatin-1及Vaspin预测胎儿出生体质量的研究[J].中国妇幼保健, 2024, 39(6): 1142-1146. DOI: 10.19829/j.zgfybj.issn.1001-4411.2024.06.042.
[20] STEFFEN T L, STAFFORD J D, SAMSON W K, et al. Nesfatin-1 is a regulator of inflammation with implications during obesity and metabolic syndrome[J]. Appetite, 2024, 203: 107669. DOI: 10.1016/j.appet.2024.107669.
[21] VÉLEZ E J, UNNIAPPAN S. Nesfatin-1 and nesfatin-1-like peptide suppress growth hormone synthesis via the AC/PKA/CREB pathway in mammalian somatotrophs[J]. Sci Rep, 2020, 10(1): 16686. DOI: 10.1038/s41598-020-73840-4.
[22] SAITO S, HASHIMOTO H, WAKASHIN H, et al. Central administered xenin induced fos expression in nesfatin-1 neurons in rats[J]. Brain Res Bull, 2023, 204: 110788. DOI: 10.1016/j.brainresbull.2023.110788.
[23] GAJEWSKA J, SZAMOTULSKA K, KLEMARCZYK W, et al. Circulating levels of nesfatin-1 and spexin in children with prader-willi syndrome during growth hormone treatment and dietary intervention[J]. Nutrients, 2023, 15(5): 1240. DOI: 10.3390/nu15051240.
[24] 曹云婷,王玮. Nesfatin-1与糖代谢关系的研究进展[J].中南大学学报(医学版), 2024, 49(6): 832-838. DOI: 10.11817/j.issn.1672-7347.2024.240113.
[25] CHEN X, DONG J, JIAO Q, et al. “Sibling” battle or harmony: crosstalk between nesfatin-1 and ghrelin[J]. Cell Mol Life Sci, 2022, 79(3): 169. DOI: 10.1007/s00018-022-04193-6.